These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23004929)

  • 1. Preclinical antitumor activity of thiarabine in human leukemia and lymphoma xenograft models.
    Waud WR; Gilbert KS; Secrist JA
    Nucleosides Nucleotides Nucleic Acids; 2012; 31(9):647-60. PubMed ID: 23004929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the in vivo antitumor activity of clofarabine by 1-beta-D-[4-thio-arabinofuranosyl]-cytosine.
    Parker WB; Shaddix SC; Gilbert KS; Shepherd RV; Waud WR
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):253-61. PubMed ID: 19002461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogs.
    Bagley RG; Roth S; Kurtzberg LS; Rouleau C; Yao M; Crawford J; Krumbholz R; Lovett D; Schmid S; Teicher BA
    Int J Oncol; 2009 May; 34(5):1329-40. PubMed ID: 19360345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical combination therapy of thiarabine plus various clinical anticancer agents.
    Waud WR; Gilbert KS; Secrist JA
    Nucleosides Nucleotides Nucleic Acids; 2012; 31(8):630-46. PubMed ID: 22908953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiarabine, 1-(4-Thio-β-D-arabinofuranosyl)cytosine. A Deoxycytidine Analog With Excellent Anticancer Activity.
    Parker WB; Waud WR; Secrist JA
    Curr Med Chem; 2015; 22(34):3881-96. PubMed ID: 26597061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of a murine P388 leukemia line resistant to clofarabine.
    Waud WR; Gilbert KS; Parker WB; Secrist JA
    Nucleosides Nucleotides Nucleic Acids; 2011 Nov; 30(11):826-38. PubMed ID: 22060549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of a murine P388 leukemia line resistant to thiarabine.
    Waud WR; Parker WB; Gilbert KS; Secrist JA
    Nucleosides Nucleotides Nucleic Acids; 2012; 31(1):14-27. PubMed ID: 22257207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of antitumor activity of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine in murine tumors.
    Furusawa S; Mian AM
    Cancer Treat Rep; 1987 May; 71(5):441-6. PubMed ID: 3567967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro antitumor assay of "half-mustard type" phenothiazines in screens of AIDS-related leukemia and lymphomas.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Molnár J
    Anticancer Res; 1997; 17(5A):3425-9. PubMed ID: 9413181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of quinocarmycin (KW2152) against various cultured leukemia and lymphoma cell lines in vitro.
    Inaba S; Shimoyama M
    Cancer Res; 1988 Nov; 48(21):6029-32. PubMed ID: 3167853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new high-performance liquid chromatography method determines low production of 9-beta-D-arabinofuranosylguanine triphosphate, an active metabolite of nelarabine, in adult T-cell leukemia cells.
    Yamauchi T; Nishi R; Kitazumi K; Nakano T; Ueda T
    Oncol Rep; 2010 Feb; 23(2):499-504. PubMed ID: 20043113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Amino-6-methoxypurine arabinoside: an agent for T-cell malignancies.
    Lambe CU; Averett DR; Paff MT; Reardon JE; Wilson JG; Krenitsky TA
    Cancer Res; 1995 Aug; 55(15):3352-6. PubMed ID: 7614470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical combination therapy of clofarabine plus radiation.
    Stackhouse MA; Gilbert KS; Scoggins JW; Waud WR
    Nucleosides Nucleotides Nucleic Acids; 2012; 31(9):692-705. PubMed ID: 23004932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of anti-cancer action and pharmacology of clofarabine.
    Zhenchuk A; Lotfi K; Juliusson G; Albertioni F
    Biochem Pharmacol; 2009 Dec; 78(11):1351-9. PubMed ID: 19576186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemia: A model for drug development.
    Keating MJ
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2598-604. PubMed ID: 9815664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dacetuzumab, a humanized mAb against CD40 for the treatment of hematological malignancies.
    Khubchandani S; Czuczman MS; Hernandez-Ilizaliturri FJ
    Curr Opin Investig Drugs; 2009 Jun; 10(6):579-87. PubMed ID: 19513947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia.
    Uno S; Kinoshita Y; Azuma Y; Tsunenari T; Yoshimura Y; Iida S; Kikuchi Y; Yamada-Okabe H; Fukushima N
    Oncol Rep; 2007 May; 17(5):1189-94. PubMed ID: 17390064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia.
    Horton HM; Bernett MJ; Pong E; Peipp M; Karki S; Chu SY; Richards JO; Vostiar I; Joyce PF; Repp R; Desjarlais JR; Zhukovsky EA
    Cancer Res; 2008 Oct; 68(19):8049-57. PubMed ID: 18829563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts.
    Verhoef V; Fridland A
    Cancer Res; 1985 Aug; 45(8):3646-50. PubMed ID: 2410098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.